NFAT regulates the expression of AIF-1 and IRT-1: Yin and yang splice variants of neointima formation and atherosclerosis

Cardiovascular Research

Volumn 93, Issue 3, 2012, Pages 414-423

  Berglund, Lisa M ^a   Kotova, Olga ^a   Osmark, Peter ^a   Grufman, Helena ^b   Xing, Chen ^c   Lydrup, Marie Louise ^b   Goncalves, Isabel ^b   Autieri, Michael V ^c   Gomez, Maria F ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIF 1; Atherosclerosis; NFAT; Restenosis; Vascular smooth muscle

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; GAMMA INTERFERON; INTERFERON; INTERFERON RESPONSIVE TRANSCRIPT 1; MESSENGER RNA; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ADENOVIRUS INFECTION; ANGIOPLASTY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY INJURY; CELL ACTIVATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE EXACERBATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MALE; NEOINTIMA; NEWBORN; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ALTERNATIVE SPLICING; ANGIOPLASTY, BALLOON, CORONARY; ANIMALS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CAROTID ARTERY INJURIES; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; MUSCLE, SMOOTH, VASCULAR; MYOMETRIUM; NEOINTIMA; NFATC TRANSCRIPTION FACTORS; ORGAN CULTURE TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84857579595     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr309     Document Type: Article

References (37)

1. Crook MF, Akyurek LM. Gene transfer strategies to inhibit neointima formation. Trends Cardiovasc Med 2003;13:102-106.
2. Shimizu K, Mitchell RN. The role of chemokines in transplant graft arterial disease. Arterioscler Thromb Vasc Biol 2008;28:1937-1949.
3. Zargham R. Preventing restenosis after angioplasty: a multistage approach. Clin Sci (Lond) 2008;114:257-264.
4. Utans U, Arceci RJ, Yamashita Y, Russell ME. Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection. J Clin Invest 1995;95:2954-2962.
5. Autieri MV. cDNA cloning of human allograft inflammatory factor-1: tissue distribution, cytokine induction, and mRNA expression in injured rat carotid arteries. Biochem Biophys Res Commun 1996;228:29-37.
6. Autieri MV, Kelemen S, Thomas BA, Feller ED, Goldman BI, Eisen HJ. Allograft inflammatory factor-1 expression correlates with cardiac rejection and development of cardiac allograft vasculopathy. Circulation 2002;106:2218-2223.
7. Sommerville LJ, Kelemen SE, Autieri MV. Increased smooth muscle cell activation and neointima formation in response to injury in AIF-1 transgenic mice. Arterioscler Thromb Vasc Biol 2008;28:47-53.
8. Sommerville LJ, Xing C, Kelemen SE, Eguchi S, Autieri MV. Inhibition of allograft inflammatory factor-1 expression reduces development of neointimal hyperplasia and p38 kinase activity. Cardiovasc Res 2009;81:206-215.
9. Mishima T, Iwabuchi K, Fujii S, Tanaka SY, Ogura H, Watano-Miyata K et al. Allograft inflammatory factor-1 augments macrophage phagocytotic activity and accelerates the progression of atherosclerosis in ApoE-/-mice. Int J Mol Med 2008;21:181-187.
10. Autieri MV, Agrawal N. IRT-1, a novel interferon-gamma-responsive transcript encoding a growth-suppressing basic leucine zipper protein. J Biol Chem 1998;273:14731-14737.
11. Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 1997;15:707-747.
12. Liu Z, Dronadula N, Rao GN. A novel role for nuclear factor of activated T cells in receptor tyrosine kinase and G protein-coupled receptor agonist-induced vascular smooth muscle cell motility. J Biol Chem 2004;279:41218-41226.
13. Liu Z, Zhang C, Dronadula N, Li Q, Rao GN. Blockade of nuclear factor of activated T cells activation signaling suppresses balloon injury-induced neointima formation in a rat carotid artery model. J Biol Chem 2005;280:14700-14708.
14. Nilsson LM, Sun Z-W, Nilsson J, Nordstrom I, Chen Y-W, Molkentin JD et al. Novel blocker of NFAT activation inhibits IL-6 production in human myometrial arteries and reduces vascular smooth muscle cell proliferation. Am J Physiol Cell Physiol 2007;292:C1167-C1178.
15. Nilsson-Berglund LM, Zetterqvist AV, Nilsson-Ohman J, Sigvardsson M, Gonzalez Bosc LV, Smith ML et al. Nuclear factor of activated T cells regulates osteopontin expression in arterial smooth muscle in response to diabetes-induced hyperglycemia. Arterioscler Thromb Vasc Biol 2010;30:218-224.
16. Autieri MV, Carbone CM. Overexpression of allograft inflammatory factor-1 promotes proliferation of vascular smooth muscle cells by cell cycle deregulation. Arterioscler Thromb Vasc Biol 2001;21:1421-1426.
17. Goncalves I, Moses J, Dias N, Pedro LM, Fernandes e Fernandes J, Nilsson J et al. Changes related to age and cerebrovascular symptoms in the extracellular matrix of human carotid plaques. Stroke 2003;34:616-622.
18. Deininger MH, Meyermann R, Schluesener HJ. The allograft inflammatory factor-1 family of proteins. FEBS Lett 2002;514:115-121.
19. Willis AE. Translational control of growth factor and proto-oncogene expression. Int J Biochem Cell Biol 1999;31:73-86.
20. Autieri MV, Chen X. The ability of AIF-1 to activate human vascular smooth muscle cells is lost by mutations in the EF-hand calcium-binding region. Exp Cell Res 2005;307:204-211.
21. Amoutzias GD, Robertson DL, Van de Peer Y, Oliver SG. Choose your partners: dimerization in eukaryotic transcription factors. Trends Biochem Sci 2008;33:220-229.
22. Sibinga NES, Feinberg MW, Yang H, Werner F, Jain MK. Macrophage- restricted and interferon gamma-inducible expression of the allograft inflammatory factor-1 gene requires Pu.1. J Biol Chem 2002;277:16202-16210.
23. Hellstrand P. Long-term effects of intracellular calcium and growth factors on excitation and contraction in smooth muscle. Acta Physiol Scand 1998;164:637-644.
24. Sims SH, Cha Y, Romine MF, Gao PQ, Gottlieb K, Deisseroth AB. A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter. Mol Cell Biol 1993;13:690-702.
25. Libby P, Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat Med 2002;8:1257-1262.
26. Del Galdo F, Maul GG, Jimenez SA, Artlett CM. Expression of allograft inflammatory factor 1 in tissues from patients with systemic sclerosis and in vitro differential expression of its isoforms in response to transforming growth factor beta. Arthritis Rheum 2006;54:2616-2625.
27. Baksh S, Widlund HR, Frazer-Abel AA, Du J, Fosmire S, Fisher DE et al. Nfatc2-mediated repression of cyclin-dependent kinase 4 expression. Mol Cell 2002;10:1071-1081.
28. Hansson GK, Jonasson L, Holm J, Clowes MM, Clowes AW. Gamma-interferon regulates vascular smooth muscle proliferation and ia antigen expression in vivo and in vitro. Circ Res 1988;63:712-719.
29. Rolfe BE, Campbell JH, Smith NJ, Cheong MW, Campbell GR. T lymphocytes affect smooth muscle cell phenotype and proliferation. Arterioscler Thromb Vasc Biol 1995;15:1204-1210.
30. Hansson GK, Holm J. Interferon-gamma inhibits arterial stenosis after injury. Circulation 1991;84:1266-1272.
31. Didion SP, Kinzenbaw DA, Schrader LI, Chu Y, Faraci FM. Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction. Hypertension 2009;54:619-624.
32. Katsuda S, Kaji T. Atherosclerosis and extracellular matrix. J Atheroscler Thromb 2003;10:267-274.
33. Krettek A, Sukhova GK, Libby P. Elastogenesis in human arterial disease: a role for macrophages in disordered elastin synthesis. Arterioscler Thromb Vasc Biol 2003;23:582-587.
34. Sommerville LJ, Kelemen SE, Ellison SP, England RN, Autieri MV. Increased atherosclerosis and vascular smooth muscle cell activation in AIF-1 transgenic mice fed a high-fat diet. Atherosclerosis (in press).
35. Heo SH, Cho C-H, Kim HO, Jo YH, Yoon K-S, Lee JH et al. Plaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease: involvement of matrix metalloproteinases 2 and 9. J Clin Neurol 2011;7:69-76.
36. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. High blood hemoglobin concentration as risk factor of major atherosclerotic cardiovascular events in 114, 159 healthy men and women in the apolipoprotein mortality risk study (AMORIS). Ann Med 2011; May 17. [Epub ahead of print].
37. Buttari B, Profumo E, Di Cristofano C, Pietraforte D, Lionetti V, Capoano R et al. Haemoglobin triggers chemotaxis of human monocyte-derived dendritic cells: possible role in atherosclerotic lesion instability. Atherosclerosis 2011;215:316-322.